Trial Profile
Effect of temozolamide on seizure frequency in patients with oligodendrogliomas
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2017
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Oligodendroglioma
- Focus Therapeutic Use
- 09 May 2017 New trial record
- 28 Apr 2017 Results presented at the 69th Annual Meeting of the American Academy of Neurology